Delivery Order SPE2DB20D2104-SPE2DB25FMNVP

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,441.30 firm fixed-price delivery order contract is for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,674.30 firm-fixed-price contract is for the supply of the medication Aimovig (140 mg/mL autoinjector) with a completion date of May 1, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $31,305.20 and is a firm fixed price, non-set-aside delivery order with a period of performance through May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,574.57 contract is for the supply of the medication Aimovig 140 mg/ml autoinjector. The contract has a period of performance through May 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,561.76 firm fixed-price contract is for the supply of the medication Aimovig 140 mg/ml autoinjector. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Aimovig 140 mg/ml autoinjector medication. The $6,866.58 firm fixed-price contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $26,227.61 delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract is a firm-fixed price, non-set-aside award with a performance period through May 8, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,377.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply the medication Aimovig 70 mg/ml autoinjector. The contract is a firm fixed-price, non-set-aside award with a period of performance through April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,934.01, is for the delivery of the medication Aimovig 140 mg/mL autoinjector. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the performance period extends through April 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp...
This federal contract award, valued at $8,129.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Aimovig 140 mg/ml autoinjectors, a medication used to treat migraine. The contract is a firm fixed-price delivery order with an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNVP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Aimovig 140 mg/ml autoinjector, with a ceiling value of $7,699.89 and a period of performance ending on April 18, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard.

Generated 7/17/25, 2:34 PM